| DGOCX | FXAIX | DGOCX / FXAIX | |
| Total Expense Ratio | 1.75 | 0.01 | 11,667% |
| Annual Report Gross Expense Ratio | 1.76 | 0.01 | 11,733% |
| Fund Existence | 28 years | 15 years | - |
| Gain YTD | 3.962 | 1.998 | 198% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 617M | 753B | 0% |
| Annual Yield % from dividends | 0.03 | 1.10 | 2% |
| Returns for 1 year | -0.85 | 17.83 | -5% |
| Returns for 3 years | -2.93 | 75.94 | -4% |
| Returns for 5 years | -14.04 | 93.74 | -15% |
| Returns for 10 years | 21.38 | 310.97 | 7% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PSL | 110.66 | 0.59 | +0.54% |
| Invesco DW Consumer Staples Momt ETF | |||
| GNMA | 44.56 | N/A | N/A |
| iShares GNMA Bond ETF | |||
| IBRN | 32.98 | N/A | N/A |
| iShares Neuroscience and Healthcare ETF | |||
| FELV | 36.30 | -0.01 | -0.04% |
| Fidelity Enhanced Large Cap Value ETF | |||
| TCAL | 23.64 | -0.07 | -0.30% |
| T. Rowe Price Capital Appreciation Premium Income ETF | |||